Patton Fund Management
MRNA icon

Patton Fund Management’s Moderna MRNA Stock Holding History

Patton Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.79M Buy
+45,656
New +$4.92M 2.26% 10
2026
Q2 		– Sell
-88,410
Closed -$4.49M – 334
2026
Q1 		$4.49M Buy
88,410
+80,920
+1,080% +$3.78M 0.76% 20
2025
Q4 		$221K Buy
+7,490
New +$203K 0.03% 354
2025
Q3 		– Sell
-10,132
Closed -$280K – 497
2025
Q2 		$280K Buy
+10,132
New +$267K 0.06% 102
2023
Q1 		– Sell
-1,155
Closed -$207K – 179
2022
Q4 		$207K Buy
+1,155
New +$189K 0.06% 158
2021
Q4 		– Sell
-3,955
Closed -$1.52M – 101
2021
Q3 		$1.52M Buy
+3,955
New +$1.46M 0.58% 58

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Patton Fund Management's MRNA Position: Q3 2026 in Review

Patton Fund Management opened a new position in Moderna (MRNA) in Q3 2026: 45,656 shares worth $8.79M. The stake represents 2.26% of the portfolio and ranks #10 among its holdings. This is a return to the name: Patton Fund Management previously reported a position in MRNA as recently as Q1 2026.

Patton Fund Management first reported a position in MRNA in Q3 2021 and has held it in 6 quarters since. 633 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Patton Fund Management held 45,656 shares of Moderna worth $8.79M as of Q3 2026.
  • Moderna was a new Patton Fund Management position in Q3 2026.
  • Moderna made up 2.26% of Patton Fund Management's portfolio in Q3 2026, its #10 holding.
  • Patton Fund Management first reported a position in Moderna in Q3 2021 and has held it in 6 quarters since.
  • 633 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Patton Fund Management's 13F filing for Q3 2026, filed 13 Oct 2026.